Hepatoma Research

hr

Search

p53 functional loss, stemness and hepatocellular carcinoma

Claude Caron de Fromentel, Massimo Levrero

Review|Published on: 6 Nov 2020
Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma

Ourania Andrisani

Review|Published on: 3 Feb 2021

Submit a Manuscript

Original Articles See more

Steatosis/steatohepatitis: how sustainable is the non-invasive instrumental differential diagnosis in clinical practice?

Antonio Salvati, ... Maurizia Rossana Brunetto

Published on: 3 Feb 2021

Feasibility of totally laparoscopic hemi-hepatectomies for liver tumor, with consideration of correspondence for difficult cases

Yuichiro Otsuka, ... Hironori Kaneko

video

Published on: 7 Jan 2021
The transcontinental variability of nonalcoholic fatty liver disease

Claudia P. Oliveira, ... Arun J. Sanyal

Published on: 12 Oct 2020
The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation

Francesca D’Arcangelo, ... Patrizia Burra

video

Published on: 7 Jan 2021
Robotic liver resection for hepatocellular carcinoma: a focus on anatomic resection

Yutaro Kato, ... Ichiro Uyama

Published on: 7 Jan 2021

Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma

Grant Yoneoka, ... Linda L. Wong

Published on: 12 Oct 2020
Implications of diameter and volume-based measurement in assessment criteria for liver transplantation for hepatocellular carcinoma

Alice I. Graham, ... Stephen J. Wigmore

Published on: 7 Jan 2021
Distinctive magnetic resonance imaging findings of hepatocellular carcinoma after hepatitis C virus eradication with direct-acting antivirals

Takao Shimizu, ... Namiki Izumi

Published on: 26 Mar 2020

Validation of novel Japanese indication criteria and biomarkers among living donor liver transplantation recipients with hepatocellular carcinoma - a single center retrospective study

Akihiko Ichida, ... Kiyoshi Hasegawa

Published on: 21 Aug 2020
Distinctive magnetic resonance imaging findings of hepatocellular carcinoma after hepatitis C virus eradication with direct-acting antivirals

Takao Shimizu, ... Namiki Izumi

Published on: 26 Mar 2020

Review Articles See more

Revisiting the role of the hepatic vein in laparoscopic liver resection

Daisuke Ban, ... Kazuaki Shimada

video

Published on: 3 Feb 2021
Detection of circulating tumor cells in hepatocellular carcinoma: applications in diagnosis, prognosis prediction and personalized treatment

Peng-Xiang Wang, ... Xin-Rong Yang

Published on: 1 Sep 2020
Liver regeneration: metabolic and epigenetic regulation

Sudhir Verma, ... Madan Mohan Chaturvedi

video

Published on: 3 Feb 2021
Genetic risk factors associated with NAFLD

Dong Yun Kim, Jun Yong Park

Published on: 5 Dec 2020

Prevalence and incidence of intra- and extrahepatic complications of NAFLD in patients with type 2 diabetes mellitus

Alessandro Mantovani, ... Andrea Dalbeni

Published on: 6 Nov 2020
Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease

Ramy Younes, ... Olivier Govaere

Published on: 3 Feb 2021
Molecular diagnosis of hepatocellular carcinoma: trends in biomarkers combination to enhance early cancer detection

Tiong Sun Chia, ... John M. Luk

Published on: 29 Mar 2019
Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases

Ken Liu, ... Geoffrey W. McCaughan

Published on: 28 Feb 2020

Others See more

Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)

Huiguo Ding, ... Specialist Committee of Cancer Prevention and Control of Chinese Preventive Medicine Association

Guideline|Published on: 25 Feb 2021

Global pattern and trend of liver cancer survival: a systematic review of population-based studies

Yu-Fei Jiang, ... Yong-Bing Xiang

Systematic Review|Published on: 15 Aug 2020
From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: is it time for a change of terminology?

Giovanni Targher, Christopher D. Byrne

Commentary|Published on: 12 Sep 2020
The secondary prevention of hepatitis B virus-associated hepatocellular carcinoma

Bo-Bin Hu, ... Jian-Ning Jiang

video

Editorial|Published on: 7 Aug 2019
No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis

Stephanie M. Rutledge, ... Raymond T. Chung

Meta-Analysis|Published on: 7 Aug 2019

Most Cited Papers In Last Two Years See more

Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation

Eric M. Wu, ... Sumodh Kalathil

Original Article|Published on: 18 Oct 2018

Oxidative stress and hepatocarcinogenesis

Ying Fu, Fung-Lung Chung

Review|Published on: 1 Aug 2018
Lycopene treatment stalls the onset of experimentally induced hepatocellular carcinoma: a radioisotopic, physiological and biochemical analysis

Nisha Bhatia, ... Ashwani Koul

Original Article|Published on: 27 Mar 2018

Elimination of hepatitis from Pakistan by 2030: is it possible?

Yasir Waheed, Masood Siddiq

Opinion|Published on: 14 Aug 2018
Molecular mechanism of hepatocellular carcinoma

Seung Kew Yoon

Review|Published on: 8 Aug 2018
Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries

Suna Yapali, Nurdan Tozun

Review|Published on: 27 Jun 2018

Ongoing Special Issues See more

Special Issue Ebooks See more

About The Journal

ISSN

2454-2520 (Online) 2394-5079 (Print)

Publisher

OAE Publishing Inc.

Article Processing Charge

$299
Editor-in-Chief

Guang-Wen Cao

Publishing Model

Gold Open Access

Copyright

Copyright is retained by authors
Publication Frequency

Continuously

Contact Us

editorialoffice@hrjournal.net

Journal Data Analysis

Total publications: 342

Total article views: 1,473,753

Total article downloads: 126,183

Membership

COPE

Hepatoma Research is a member of the Committee on Publication Ethics (COPE) and fully adhere to its Code of Conduct and to its Best Practice Guidelines.
STM

Hepatoma Research (hr) is a member of and subscribes to the principles of STM. Authors of hr can reuse a certain quantity of article contents from the chargeable publications of other STM members for free in their submissions to hr.
ORCID

Hepatoma Research (hr) is a member of ORCID and MESAs system has been connected with ORCID. After submissions to hr are published, they will be automatically synchronized to the authors' ORCID accounts if the authors have connected their MESAs accounts with ORCID accounts. hr's reviewers can choose to synchronize their review records to their ORCID accounts when filling in review reports.
Crossref

Hepatoma Research is a member of Crossref, which makes research outputs easy to find, cite, link, assess, and reuse.
iThenticate

All submissions to Hepatoma Research are checked for plagiarism by iThenticate.
Check for updates

All published articles in Hepatoma Research are enriched with a record of the current article status.

Open Archives

Portico

All published articles will be preserved here permanently:
https://www.portico.org/

Partners